Arbios Systems, Inc.'s (OTC Bulletin Board: ABOS) Q3/07 Analyst Review Issued by Scimitar Equity Research, Inc.
December 03 2007 - 9:00AM
PR Newswire (US)
BOSTON, Dec. 3 /PRNewswire/ -- Scimitar Equity Research, Inc.
(Scimitar) today issued a review on Arbios Systems, Inc. (OTC:ABOS)
(BULLETIN BOARD: ABOS) entitled: "A New Tool for Rescuing Patients
who's Livers Are Failing." The analyst research review is available
on Scimitar's website: http://www.scimitarequity.com/. Arbios
Systems, Inc. is developing proprietary medical devices and cell-
based therapies to enhance the survival of millions of patients
each year who experience, or are at risk for, life-threatening
episodes of liver failure. The Arbios product candidate portfolio
includes the SEPET(TM) Liver Assist Device, a novel blood
purification therapy that provides enhanced "liver dialysis," and
the HepatAssist(TM) Cell-Based Liver Support System, a
bioartificial liver that combines blood detoxification with liver
cell therapy to replace whole liver function in patients with the
most severe forms of liver failure. For more information on Arbios,
please visit http://www.arbios.com/. Scimitar Equity Research, Inc.
provides sponsored equity research of emerging healthcare companies
for the investing communities. We certify that all the views
expressed in this review, accurately reflect our personal views
about (OTC:ABOS) (BULLETIN BOARD: ABOS) No part of our compensation
was, is, or will be, directly or indirectly, related to the
specific recommendations or views contained in this review and we
will not have any investment banking relationships or personal
investment in any sponsored company. Investors are advised that
this analysis and review is issued solely for informational
purposes and is not to be construed as an offer to sell or the
solicitation of an offer to buy. Scimitar was paid for preparing
this review. This analysis and review does not have regard to the
specific investment objectives, financial situation and the
information contained herein is based on sources that we believe to
be reliable but is not guaranteed by us as being accurate and does
not purport to be a complete statement or summary of the available
data. Any opinions expressed are statements of our own judgment as
of the date of publication and are subject to change without
notice. Please read all our important disclosures. CONTACT:
Scimitar Equity Research, Inc. Henry W. McCusker Director of
Research phone: (617) 559-1080 fax: (617) 559-1083 e-mail:
DATASOURCE: Scimitar Equity Research, Inc. CONTACT: Henry W.
McCusker, Director of Research of Scimitar Equity Research, Inc.,
phone, +1-617-559-1080, fax, +1-617-559-1083, Web site:
http://www.scimitarequity.com/ http://www.arbios.com/
Copyright